Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

13D Filing: Okumus Fund Management is Still Activist on Ascent Capital Group, Inc. (ASCMA)

Page 1 of 6

Ahmet OkumusOkumus Fund Management has just filed a Form 13D with the SEC, updating the regulatory body on its position in Ascent Capital Group Inc (NASDAQ:ASCMA). The activist filing shows that the fund’s position in the company has remained unchanged from the end of 2015 at just under 1.29 million shares, and that it was filed to refute a mistakenly-filed 13G on the company earlier today, which would’ve suggested that the fund was no longer an activist shareholder of the stock. You can see the latest ownership position in the table below, while the filing is embedded below and on the following pages.

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Okumus Fund Management Ltd 0 1,289,727 0 1,289,727 1,289,727 10.5%
Okumus Opportunistic Value Fund, Ltd 0 1,289,727 0 1,289,727 1,289,727 10.5%
Ahmet H. Okumus 0 1,289,727 0 1,289,727 1,289,727 10.5%
Ahmet Okumus
Ahmet Okumus
Okumus Fund Management

Page 1 of 6 SEC Filing

(Amendment No. 1)
Ascent Capital Group, Inc.
(Name of Issuer)
Series A Common Stock, $0.01 par value
(Title of Class of Securities)
(CUSIP Number)
c/o Okumus Fund Management Ltd.
767 Third Avenue, 35th Floor
New York, NY 10017
(Name, Address and Telephone Number of Person Authorized to Receive
Notices and Communications)
February 16, 2016
(Date of Event Which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of ss.240.13D-1(e), 240.13d‑1(f) or 240.13d-1(g), check the following box [X ].
Follow Ascent Capital Group Inc. (NASDAQ:ASCMA)
Page 1 of 6

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!